Glembatumumab (Anti-GPNMB)

Ask supplier a question | View on supplier's website

Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2475
Sku #	A2475-1mg
Pricing	1mg, $370.00

Feedback